Koers Vinings Holdings Inc. Other OTC
Aandelen
NDYN
US92744A1051
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 26,74 mln. 24,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -37 mln. -34,15 mln. | Nettowinst (verlies) 2023 | -21 mln. -19,38 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 2,08 mln. 1,92 mln. | Nettoliquiditeiten 2023 | 245K 226K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,58
x | K/w-verhouding 2023 |
-0,95
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 68,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28-10-22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17-05-23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 62 | 28-10-22 | |
Director/Board Member | 55 | 28-10-22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,69% | 728 mld. | |
+33,55% | 603 mld. | |
-4,49% | 360 mld. | |
+20,24% | 332 mld. | |
+2,12% | 279 mld. | |
+15,77% | 244 mld. | |
+7,71% | 207 mld. | |
-5,44% | 205 mld. | |
-0,35% | 163 mld. |